Bio Usawa appoints Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors.

{
  "signal_id": "0546c1f3-c2c3-44b7-96a6-44a70f2a2146",
  "signal_type": "news",
  "signal_subtype": "leaves",
  "detected_at": "2026-06-15T08:00:00+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "url": "https://www.mycarrollcountynews.com/online_features/press_releases/article_ea170054-de6d-5331-b54b-09ed3b5f89f5.html",
    "title": "Bio Usawa appoints Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors.",
    "ticker": "NYSE:PFE",
    "contact": "Aida Habtezion",
    "excerpt": "Bio Usawa appoints Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors.\n\n* 3 hrs ago\n\nKIGALI, Rwanda and SAN FRANCISCO, June 15, 2026 (GLOBE NEWSWIRE) - Bio Usawa, a biotechnology company dedicated to expanding access to high-quality biologic medicines across Africa, today announced the appointment of Dr. Aida Habtezion to its Board of Directors. Her appointment marks a significant milestone as the company accelerates its efforts to build sustainable biotechnology manufacturing capacity on the continent and improve access to life-changing therapies for patients across Africa.\n\nStrait of Hormuz Is Source of Asset Pain: 3-Minutes MLIV\n\nDr. Habtezion is an internationally recognized physician-scientist, healthcare executive, and academic leader whose distinguished career spans academic medicine, translational research, clinical innovation, and the development of transformative medicines. Most recently, she served as Chief Medical Officer and Head of Worldwide Medical & Safety at Pfizer, where she led global medical and patient safety activities across a diverse portfolio of innovative therapeutics and vaccines, helping to advance treatments that have improved the lives of millions worldwide.\n\nHer appointment comes at a pivotal time for Bio Usawa as the company advances its vision of establishing world-class biomanufacturing capabilities in...",
    "summary": "Aida Habtezion left Pfizer Inc as Chief Medical Officer and Head of Worldwide Medical & Safety on Jun 15th '26.",
    "planning": false,
    "image_url": "https://bloximages.newyork1.vip.townnews.com/mycarrollcountynews.com/content/tncms/custom/image/7bb34d62-4966-11e8-99d7-bb8f740bd4ec.jpg?resize=600%2C315",
    "job_title": "Chief Medical Officer and Head of Worldwide Medical & Safety",
    "confidence": 0.7832,
    "published_at": "2026-06-15T08:00:00Z",
    "effective_date": "2026-06-15",
    "job_title_tags": [
      "management"
    ],
    "article_sentence": "Bio Usawa appoints Dr. Aida Habtezion, former Chief Medical Officer at Pfizer, to its Board of Directors."
  }
}

curl https://signals.autobound.ai/v1/signals/0546c1f3-c2c3-44b7-96a6-44a70f2a2146 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"pfizer.com","limit":20}'